See also this year's filing and all EDGAR filings for this company.
PDF Report 0001344413_2015_Alexza_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001344413, Alexza Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 41,785,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 13,953,000 |
| 3 | remainder_Assets | 5,822,000 |
| 4 | LiabilitiesCurrent | 11,517,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,344,000 |
| 9 | ResearchAndDevelopmentExpense | 13,748,000 |
| 10 | remainder_Expenses | 15,214,000 |
| 11 | remainder_Revenues | 5,561,000 |
| 12 | remainder_NetIncome | 13,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 61,560,000 |
| 1 | Liabilities | 11,517,000 |
| 2 | Expenses | 42,306,000 |
| 3 | Revenues | 5,561,000 |
| 4 | StockholdersEquity | 50,043,000 |
| 5 | NetIncome | -36,732,000 |
| 6 | ComprehensiveNetIncome | -36,732,000 |
| 7 | BaseVar | 60,478,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.98 |
| 9 | EconomicCapitalRatio | 3.01 |
Edgar->Model Mapping
Feature Distribution
Change over Time
